Clinical Trial Update: A Safety and Tolerability Study of Administration of PSD502 [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the safety and tolerability of PSD502 for premature ejaculation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• PSD502

Snippet

Sponsor: Plethora Solutions Ltd | Conditions: Premature Ejaculation | Phase 1 | Status: COMPLETED